» Articles » PMID: 26540497

Exhaled NO: Determinants and Clinical Application in Children With Allergic Airway Disease

Overview
Date 2015 Nov 6
PMID 26540497
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide (NO) is endogenously released in the airways, and the fractional concentration of NO in exhaled breath (FeNO) is now recognized as a surrogate marker of eosinophilic airway inflammation that can be measured using a noninvasive technique suitable for young children. Although FeNO levels are affected by several factors, the most important clinical determinants of increased FeNO levels are atopy, asthma, and allergic rhinitis. In addition, air pollution is an environmental determinant of FeNO that may contribute to the high prevalence of allergic disease. In this review, we discuss the mechanism for airway NO production, methods for measuring FeNO, and determinants of FeNO in children, including host and environmental factors such as air pollution. We also discuss the clinical utility of FeNO in children with asthma and allergic rhinitis and further useful directions using FeNO measurement.

Citing Articles

Preoperative fractional exhaled nitric oxide is a risk and predictive factor of postoperative cough for early-stage non-small cell lung cancer patients: a longitudinal study.

Lin R, Yu G, Tu X BMC Pulm Med. 2024; 24(1):598.

PMID: 39623395 PMC: 11613588. DOI: 10.1186/s12890-024-03413-y.


The Relationship of Fractional Exhaled Nitric Oxide in Patients with AECOPD.

Xu X, Zhou L, Tong Z Int J Chron Obstruct Pulmon Dis. 2023; 18:3037-3046.

PMID: 38146507 PMC: 10749541. DOI: 10.2147/COPD.S434040.


Can the Chinese study on the normal range of FeNO in children evaluate standardized asthma treatment efficacy in 6- to 12-year-old children?.

Yang Q, Cai C, Xu Q, Zheng Y, Li A, Liu Y Front Pediatr. 2023; 11:1189496.

PMID: 37794961 PMC: 10546037. DOI: 10.3389/fped.2023.1189496.


A cross-sectional analysis of medical conditions and environmental factors associated with fractional exhaled nitric oxide (FeNO) in women and children from the ISA birth cohort, Costa Rica.

Werthmann D, van Wendel de Joode B, Cuffney M, Reich B, Soto-Martinez M, Corrales-Vargas A Environ Res. 2023; 233:116449.

PMID: 37356534 PMC: 10529647. DOI: 10.1016/j.envres.2023.116449.


Economic impact of a more extensive use of FENO testing on the Italian population with asthma.

Rognoni C, Milano C, Heffler E, Bonini M, Brussino L, Carpagnano G Respir Res. 2023; 24(1):147.

PMID: 37268938 PMC: 10236694. DOI: 10.1186/s12931-023-02437-y.


References
1.
Cho H, Jung Y, Yang S, Lee E, Kim H, Seo J . Reference values and determinants of fractional concentration of exhaled nitric oxide in healthy children. Allergy Asthma Immunol Res. 2014; 6(2):169-74. PMC: 3936047. DOI: 10.4168/aair.2014.6.2.169. View

2.
Taylor E, Smith A, Cowan J, Herbison G, Taylor D . Effect of caffeine ingestion on exhaled nitric oxide measurements in patients with asthma. Am J Respir Crit Care Med. 2004; 169(9):1019-21. DOI: 10.1164/rccm.200310-1473OC. View

3.
Gadish T, Soferman R, Merimovitch T, Fireman E, Sivan Y . Exhaled nitric oxide in acute respiratory syncytial virus bronchiolitis. Arch Pediatr Adolesc Med. 2010; 164(8):727-31. DOI: 10.1001/archpediatrics.2010.128. View

4.
Hung C, Hua Y, Hsu W, Lai Y, Yang K, Jong Y . Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis. Pediatr Int. 2007; 49(3):322-7. DOI: 10.1111/j.1442-200X.2007.02375.x. View

5.
Cowan D, Cowan J, Palmay R, Williamson A, Taylor D . Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2009; 65(5):384-90. DOI: 10.1136/thx.2009.126722. View